Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4
International Journal of Molecular Sciences · 28.06.2025 · 26 (13) · 6240
DOI: 10.3390/ijms26136240 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.06.2025. Verfasst von Lucía Cremades-Jimeno und 16 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Asthma, Toll-Like Receptor 4, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded in part by research grant PI20/00903 and PI23/00524 cofunded by FEDER, CIBERES (ISCIII, 0013), RETIC (RD09/0076/00101) from the Fondo…, FEDER, CIBERES (ISCIII, 0013), RETIC (RD09/0076/00101) from the Fondo de Investigación Sanitaria (Ministerio de Ciencia, Innovación y Universidades, Spain), Ayudas de la Sociedad Española de Alergia e Inmunología Clínica (SEAIC).
Abstract (Originalsprache)
Asthma is a chronic and heterogeneous inflammatory airway disease with diverse clinical endotypes and limited curative treatment options. Recent systems biology analyses identified four potential molecular triggers—AKT1, MAPK13, STAT1, and TLR4—as candidate regulators of asthma-associated signaling pathways. This study aimed to validate the expression of these four proteins and their downstream signaling elements in peripheral blood mononuclear cells (PBMCs) from patients with allergic asthma (AA), nonallergic asthma (NA), and healthy controls (HC), to explore their potential as biomarkers or therapeutic targets. For that, PBMC samples were collected from 45 AA patients, 17 NA patients, and 15 HC subjects. Gene and protein expression of AKT1, MAPK13, STAT1, and TLR4 were quantified using RT-qPCR and Western blotting. Expression patterns were compared across groups and stratified by asthma severity. Correlations with clinical parameters (FEV1, FVC, FeNO, IgE, eosinophil counts) and treatment regimens were also assessed. All four target genes showed significantly reduced expression in asthma patients compared to controls (p < 0.001), with the most marked downregulation in NA patients. At the protein level, MAPK13 and TLR4 showed significant differential expression. Stratification by severity revealed a stepwise reduction in gene expression in AA patients, correlating with disease severity, whereas NA patients showed uniformly low expression regardless of severity. Multiple pathway-related genes, including RELA, SMAD3, NFATC1, and ALOX5, were also downregulated, particularly in NA patients. Notably, differential correlations were observed between gene expression and lung function parameters in AA vs. NA groups. In conclusion, this study supports the potential involvement of AKT1, MAPK13, STAT1, and TLR4 in asthma pathogenesis and highlights differences between allergic and nonallergic asthma at the molecular level. These proteins and their associated pathways may serve as future targets for biomarker development or endotype-specific therapies. Further studies in larger and more diverse cohorts, including functional validation, are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Department, IIS-Fundación Jiménez Díaz-UAM, 28040 Madrid, Spain.
- Biostatistics and Epidemiology Unit, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
- Allergology Service, University Hospital of Navarra, 31008 Pamplona, Spain.
- Ciber de Enfermedades Respiratorias (CIBERES), 28029 Madrid, Spain.
- Department of Allergy, La Paz University Hospital, IdiPAZ, 28029 Madrid, Spain.
- Allergy Department, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain.
ORCID-Profile: Lucía Cremades-Jimeno, Rubén Fernández-Santamaría, María Ángeles De Pedro, Ignacio Mahillo, Victoria Del Pozo, María Luisa Caballero, Juan Alberto Luna-Porta, Santiago Quirce, Selene Baos, Blanca Cárdaba
Förderung
- This research was funded in part by research grant PI20/00903 and PI23/00524 cofunded by FEDER, CIBERES (ISCIII, 0013), RETIC (RD09/0076/00101) from the Fondo…
- FEDER, CIBERES (ISCIII, 0013), RETIC (RD09/0076/00101) from the Fondo de Investigación Sanitaria (Ministerio de Ciencia, Innovación y Universidades, Spain)
- Ayudas de la Sociedad Española de Alergia e Inmunología Clínica (SEAIC)
- Fundación Conchita Rábago
- Comunidad de Madrid
- Fondo Social Europeo (FSE)
- Iniciativa de Empleo Juvenil (IEJ)
- Fondo de Investigación Sanitaria (Ministerio de Ciencia, Innovación y Universidades, Spain)
Zitieren
APA
Cremades-Jimeno, L., López-Ramos, M., Fernández-Santamaría, R., De Pedro, M. Á., Mahillo, I., Rosales-Ariza, C., Olaguibel, J. M., Pozo, V. D., Caballero, M. L., Luna-Porta, J. A., Quirce, S., Barroso, B., Betancor, D., Valverde-Monge, M., Sastre, J., Baos, S., & Cárdaba, B. (2025). Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4. International Journal of Molecular Sciences, 26(13), 6240. https://doi.org/10.3390/ijms26136240
Vancouver
Cremades-Jimeno L, López-Ramos M, Fernández-Santamaría R, De Pedro MÁ, Mahillo I, Rosales-Ariza C, et al. Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4. International Journal of Molecular Sciences. 2025;26(13):6240. doi:10.3390/ijms26136240
BibTeX
@article{CremadesJimeno2025,
author = {Cremades-Jimeno, Lucía and López-Ramos, María and Fernández-Santamaría, Rubén and De Pedro, María Ángeles and Mahillo, Ignacio and Rosales-Ariza, Cristina and Olaguibel, José María and Pozo, Victoria Del and Caballero, María Luisa and Luna-Porta, Juan Alberto and Quirce, Santiago and Barroso, Blanca and Betancor, Diana and Valverde-Monge, Marcela and Sastre, Joaquín and Baos, Selene and Cárdaba, Blanca},
title = {Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6240},
doi = {10.3390/ijms26136240}
}
EUVIMED